Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Finance topic
No spam. Unsubscribe anytime.
Lawmakers hear competing views on 340B transparency bill as hospitals warn of burden
Summary
HB 17‑55 would require expanded reporting and enforcement around the federal 340B drug‑pricing program. The bill’s sponsor said it would bring sunlight to alleged abuses; hospitals and FQHCs warned state rules could duplicate HRSA oversight and risk program participation. DHHS and the Attorney General’s Charitable Trust Unit offered to supply more data for committee review.
Representative Yuri Polozov told the committee HB 17‑55 seeks transparency and accountability for New Hampshire entities participating in the federal 340B drug‑pricing program, saying some hospitals may benefit financially without commensurate charity care. He cited national reports alleging that hospitals have sometimes charged patients collection fees while retaining 340B savings, and he argued a sunshine and enforcement approach — including more reporting and the Charitable Trust Unit's ability to refer matters to the IRS — could address abuse.
The Department of Health and Human Services (Henry Lipman, Medicaid Director) urged caution. Lipman said New Hampshire already captures 340B rebates related to Medicaid beneficiaries and estimated the state could lose between $10 million and $30 million in general funds (or $20–$60 million with federal match) if the bill discouraged 340B participation; he also warned of timing and resource constraints for collecting and operating new reporting systems.
Mary Anne Dempsey, director of the Charitable Trust Unit at the Attorney General’s Office, told the committee CTU performs high‑level oversight of registered nonprofits and publishes community benefits reports under RSA 7:32‑b, but she said the granular program‑level financial reviews the bill would require are operationally difficult and would demand additional resources. Hospital association witnesses called HB 17‑55 an unnecessary state compliance overlay on a federally regulated program overseen by HRSA and warned of administrative burdens for critical access hospitals. Community health centers and FQHC representatives said 340B savings fund services for vulnerable patients and cautioned that heavy state reporting could reduce participation and harm services.
Committee members asked DHHS and CTU to return with concrete data and reporting options; no committee vote was taken.
